Computational Analysis of ELOVL6 Structure and Inhibition for Rational Drug Design

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• ELOVL6 is crucial for fatty acid elongation, converting C16 to C18 fatty acids.
• Dysregulation of ELOVL6 is implicated in metabolic and neurodegenerative diseases.
• Lack of structural data and mechanistic insight hinders ELOVL6 inhibitor development.

Purpose of the Study:

• Investigate the structural basis of ELOVL6 function and inhibition using computational methods.
• Identify substrate binding pathways and conformational changes upon ligand interaction.
• Provide insights for structure-based drug design targeting ELOVL6.

Main Methods:

• Structure prediction
• Molecular dynamics (MD) simulations
• Free energy calculations
• Inhibitor binding pocket analysis
• Homology comparisons

Main Results:

• Identified the most stable substrate binding pathway for ELOVL6.
• Characterized conformational dynamics related to ligand binding.
• Confirmed active site targeting by known inhibitors and validated binding affinities.
• Pinpointed key residues for ELOVL6 selectivity over homologous enzymes.

Conclusions:

• Established a mechanistic framework for ELOVL6 inhibition.
• Provided insights for rational drug design of ELOVL6-targeting therapeutics.
• Laid the groundwork for optimizing ELOVL6-based therapies for associated diseases.